Clinical Trial Update: Succinylated Human Serum Albumin (Suc-HSA) for HIV-1 Infection [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating succinylated human serum albumin (Suc-HSA) for HIV infection has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Suc-HSA (succinylated human serum albumin) (succinylated human serum albumin)

Snippet

Sponsor: International Antiviral Therapy Evaluation Center | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED